Drug manufacturers have increased their production, and some such as Novo Nordisk have asked the FDA to ban further production of compounded versions of their drugs. If that happens, Lavin says many ...

As millions patients struggled to fill their prescriptions for the new weight loss drugs, many have turned to compounded copies.

The semaglutide ... weight loss, she says that the clinic is “seeing more interest from slim individuals, particularly women, who are exploring GLP-1 agonists” for brain health and longevity benefits.

The drugs include Mounjaro, also known as tirzepatide, and semaglutide, which is sold under the brand names Wegovy, Ozempic ...

A surprise amount of Brits say they would take anti-obesity drugs if they were given to them for free on the ...

The ads promise GLP-1 medications for diabetes and weight loss delivered to your door at prices that can’t be beaten. It ...

U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...

Novo Nordisk (NVO) has reportedly launched its popular weight-loss drug Wegovy in China ahead of a rival drug by Eli Lilly ...

State Medicaid programs for low-income families are the single biggest source of coverage, giving 31.6 million people access ...

Pharmacies that make customized medications are asking the federal Food and Drug Administration to protect their right to ...

Researchers at the University of Copenhagen have identified a new drug target for weight loss that curbs appetite, boosts ...